Absci (ABSI) Change in Acquisitions & Divestments (2022 - 2026)
Absci (ABSI) posted Change in Acquisitions & Divestments of $26.0 million for Q1 2026, up 503.25% sequentially from $4.3 million in Q4 2025, and up 4.0% YoY from $25.0 million in Q1 2025.
Analysis
Absci (ABSI) Change in Acquisitions & Divestments (2022 - 2026) Analysis & Trends
Absci has reported Change in Acquisitions & Divestments for 5 years, with the latest figure at $26.0 million in Q1 2026.
- Quarterly Change in Acquisitions & Divestments rose 4.0% year-over-year to $26.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $70.5 million (down 52.52% YoY) and the FY2025 annual result came in at $69.5 million, down 51.74% from the prior year.
- Change in Acquisitions & Divestments advanced to $26.0 million in Q1 2026 per ABSI's latest filing, from $4.3 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $93.9 million in Q2 2023 and troughed at $4.3 million in Q4 2025.
- A 5-year average of $33.9 million and a median of $30.8 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
- The sharpest annual moves came in 2023 and 2025: Change in Acquisitions & Divestments surged 780.0% in 2023, then sank 90.42% in 2025.
- Over 5 years, Change in Acquisitions & Divestments stood at $5.0 million in 2022, then jumped by 780.0% to $44.0 million in 2023, then climbed by 2.27% to $45.0 million in 2024, then tumbled by 90.42% to $4.3 million in 2025, then jumped by 503.25% to $26.0 million in 2026.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $26.0 million, $4.3 million, and $14.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Absci | 1.39 Bn | 1.19 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.99 Mn |
| Mar 31, 2026 | 26.00 Mn |
| Dec 31, 2025 | 4.31 Mn |
| Sep 30, 2025 | 14.19 Mn |
| Jun 30, 2025 | 26.00 Mn |
| Mar 31, 2025 | 25.00 Mn |
| Dec 31, 2024 | 45.00 Mn |
| Sep 30, 2024 | 43.00 Mn |
| Jun 30, 2024 | 35.50 Mn |
| Mar 31, 2024 | 20.50 Mn |
| Dec 31, 2023 | 44.00 Mn |
| Sep 30, 2023 | 50.00 Mn |
| Jun 30, 2023 | 93.90 Mn |
| Mar 31, 2023 | 42.00 Mn |
| Dec 31, 2022 | 5.00 Mn |